These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28832714)

  • 1. Ki-67 protein predicts survival in oral squamous carcinoma cells: an immunohistochemical study.
    Lopes VKM; Jesus AS; Souza LL; Miyahara LAN; Guimarães DM; Pontes HAR; Pontes FSC; Carvalho PL
    Braz Oral Res; 2017 Aug; 31():e66. PubMed ID: 28832714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear metallothionein in oral squamous cell carcinoma: clinicopathological parameters and patient survival.
    Bezerra GMDR; Pontes FSC; Conte Neto N; Nascimento LSD; Souza LL; Pinto Junior DDS; Pontes HAR
    Braz Oral Res; 2018 Oct; 32():e105. PubMed ID: 30328895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCM3: A Novel Proliferation Marker in Oral Squamous Cell Carcinoma.
    Valverde LF; de Freitas RD; Pereira TA; de Resende MF; Agra IMG; Dos Santos JN; Dos Reis MG; Sales CBS; Gurgel Rocha CA
    Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):120-125. PubMed ID: 27258565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
    Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
    J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p-Akt and its relationship with clinicopathological features and survival in oral squamous cell carcinoma: an immunohistochemical study.
    Pontes HA; Pontes FS; de Jesus AS; Soares MC; Gonçalves FL; de Lucena Botelho T; do Carmo Ribeiro J; Dos Santos Pinto D
    J Oral Pathol Med; 2015 Aug; 44(7):532-7. PubMed ID: 25244056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
    Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
    Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of high Ki-67 expression in stage I oral squamous cell carcinoma specimens after primary surgery.
    Freudlsperger C; Rohleder SE; Reinert S; Hoffmann J
    Head Neck; 2011 May; 33(5):668-72. PubMed ID: 20687171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of increased twist with lymph node metastasis in patients with oral squamous cell carcinoma.
    Wushou A; Pan HY; Liu W; Tian Z; Wang LZ; Shali S; Zhang ZY
    J Oral Maxillofac Surg; 2012 Jun; 70(6):1473-9. PubMed ID: 21864967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma.
    Camisasca DR; Honorato J; Bernardo V; da Silva LE; da Fonseca EC; de Faria PA; Dias FL; Lourenço Sde Q
    Oral Oncol; 2009 Mar; 45(3):225-33. PubMed ID: 18715811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p63 and Ki-67 immunostainings in laryngeal squamous cell carcinoma are related to survival.
    Re M; Zizzi A; Ferrante L; Stramazzotti D; Goteri G; Gioacchini FM; Olivieri F; Magliulo G; Rubini C
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1641-51. PubMed ID: 24402377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.
    Montebugnoli L; Gissi DB; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
    J Oral Maxillofac Surg; 2011 Oct; 69(10):2579-84. PubMed ID: 21292374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas.
    da Silva SD; Cunha IW; Nishimoto IN; Soares FA; Carraro DM; Kowalski LP; Graner E
    Oral Oncol; 2009 Oct; 45(10):e134-9. PubMed ID: 19362044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
    Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
    da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
    Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence.
    Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S
    Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing Fascin over-expression as a strategic regulator of neoplastic aggression and lymph node metastasis in oral squamous cell carcinoma tumor microenvironment.
    Routray S; Kheur S; Chougule HM; Mohanty N; Dash R
    Ann Diagn Pathol; 2017 Oct; 30():36-41. PubMed ID: 28965626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
    Nemes JA; Nemes Z; Márton IJ
    J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients.
    Myoung H; Kim MJ; Lee JH; Ok YJ; Paeng JY; Yun PY
    Int J Oral Maxillofac Surg; 2006 Nov; 35(11):1005-10. PubMed ID: 17018251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma.
    Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.